Johnson & Johnson
NYSE: JNJ
$267.28
+0.08
(+0.03%)
as on
Johnson & Johnson Stock Performance
as on September 17, 2026 at 2:16 pm IST
Day's Low
Day's High
$266.30$268.65
0.37%
Downside
0.51%
Upside
52 Week's Low
52 Week's High
$173.33$281.0735.15%
Downside
5.16%
Upside
Johnson & Johnson share price movements today
- Previous Close
- $267.20
- Open
- $267.20
- Volume
- 2.7M
- Market Cap
- $640.0B
- Dividend Yield
- 1.99%
- Day's Low - High
- $266.30 - $268.65
- 52 Week Low - High
- $173.33 - $281.07
Johnson & Johnson Historical Returns
- 1 Month Return
- + 2.29 %
- 3 Month Return
- + 13.01 %
- 1 Year Return
- + 50.12 %
- 3 Year Return
- + 64.96 %
- 5 Year Return
- + 61 %
Johnson & Johnson Stock Fundamentals & Key Indicators
Check Johnson & Johnson market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$640.0B
EPS (TTM)
8.65
Dividend Yield
1.99%
Quarterly Earnings Growth YOY
-0.01%
PE Ratio (TTM)
30.7
Industry PE ratio
25.75
PEG Ratio
-3.801502585944636
EBITDA
33.7B
Revenue (TTM)
97.9B
Profit Margin
70.45%
Return On Equity TTM
25.74%
Johnson & Johnson Stock Valuation
Track how Johnson & Johnson P/E has moved over time to understand its valuation trends.
Johnson & Johnson in the last 5 years
Lowest (11.30x)
December 31, 2023
Today (18.82x)
December 31, 2025
Industry (25.75x)
December 31, 2025
Highest (25.73x)
December 31, 2022
Today’s Price to Earnings Ratio: 18.82x
Johnson & Johnson vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Johnson & Johnson with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| BUY | $640.0B | 61% | 30.7 | 70.45% | 198.81% | |
| BUY | $337.4B | 0.7% | 21.94 | 18.44% | 295.35% | |
| HOLD | $158.0B | -38.08% | 35.41 | 71.32% | 620.49% |
Stock Returns calculator for Johnson & Johnson Stock including INR - Dollar returns
The Johnson & Johnson stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Johnson & Johnson investment value today
Current value as on today
₹1,64,478
Returns
₹64,478
(+64.48%)
Returns from Johnson & Johnson Stock
₹50,665 (+50.67%)
Dollar Impact
₹13,813 (+13.81%)
Analyst Recommendation on Johnson & Johnson Stock
Based on 18 analysts
77.78%
Buy
22.22%
Hold
0.00%
Sell
Based on 18 analysts, 77.77777777777779% of analysts recommend a 'BUY' rating for Johnson & Johnson. Average target price of $277.91
Johnson & Johnson Share Price Target
Get share price movements and forecasts by analysts on Johnson & Johnson.
What analysts predicted
3.82%UPSIDE
Target Price
$277.91
Current Price
$267.28
Analyzed by
18 Analysts
Target
$277.91
Johnson & Johnson target price $277.91, a slight upside of 3.82% compared to current price of $267.28. According to 18 analysts rating.
Indian Investors' Interest in Johnson & Johnson Stock
Search interest for Johnson & Johnson Stock has decreased by -17% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Johnson & Johnson Quarterly Profit & Loss
All numbers in Millions USD
Johnson & Johnson Annual Profit & Loss
All numbers in Millions USD
Johnson & Johnson Quarterly Cash Flow
All numbers in Millions USD
Johnson & Johnson Annual Cash Flow
All numbers in Millions USD
Johnson & Johnson News & Key Events
Today's Timeline - 16 September
Wed, 04:28 PM
-Johnson & Johnson sells Laminar LAA closure assets less than three years after acquiring them for $400 million.
Thu, 00:42 AM
-J&J's sales rose 5.6% despite STELARA drag; management emphasizes growth excluding STELARA's impact.
Thu, 00:59 AM
-Caplyta shows improved sexual functioning in depression patients, strengthening J&J's competitive position in psychiatry.
Today's Timeline - 16 September
Thu, 12:42 PM
-J&J reports improved survival data for RYBREVANT in EGFR-mutated lung cancer, enhancing its drug pipeline outlook.
Insights on Johnson & Johnson
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Johnson & Johnson has shown positive revenue growth over the last two quarters, with revenue increasing from $24.06 billion to $25.30 billion. This reflects an average increase of 4.9% per quarter.
- POSITIVE IMPACT
Profit Spike
Johnson & Johnson has shown a positive trend in its net profit over the last three quarters. The company's net profit increased from $5.11 billion to $5.53 billion, achieving an average growth of 3.8% per quarter.
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, JNJ has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, JNJ has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 3 months, JNJ stock has moved up by 14.1%
About Johnson & Johnson
| Organisation | Johnson & Johnson |
| Headquarters | One Johnson & Johnson Plaza, New Brunswick, NJ, United States, 08933 |
| Industry | Drug Manufacturers - General |
| CEO | Mr. Joaquin Duato |
| E-voting on shares | Click here to vote |
Key Management of Johnson & Johnson
Name | Title |
|---|---|
Mr. Timothy Schmid | Executive VP & Worldwide Chairman of MedTech |
Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer |
Mr. Dirk Brinckman | Chief Compliance Officer |
Ms. Elizabeth Forminard J.D. | Executive VP & Chief Legal Officer |
Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine and R&D |
Mr. Joseph James Wolk CPA | Executive VP & CFO |
Mr. James Swanson | Executive VP & Chief Information Officer |
Mr. Ryan Koors | Vice President of Investor Relations |
Ms. Kristen Blair Mulholland | Executive VP & Chief HR Officer |
Mr. Joaquin Duato | CEO & Chairman |
FAQs
What is Johnson & Johnson share price today?
Johnson & Johnson share price today is $267.28 as on at the close of the market. Johnson & Johnson share today touched a day high of $268.65 and a low of $266.30.
What is the 52 week high and 52 week low for Johnson & Johnson share?
Johnson & Johnson share touched a 52 week high of $281.07 on and a 52 week low of $173.33 on . Johnson & Johnson stock price today i.e. is closed at $267.28,which is 4.91% down from its 52 week high and 54.20% up from its 52 week low.
What is Johnson & Johnson's market capitalisation today?
Johnson & Johnson market capitalisation is $0.64T as on .
How to invest in Johnson & Johnson Stock (JNJ) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Johnson & Johnson on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Johnson & Johnson Shares that will get you 0.0056 shares as per Johnson & Johnson share price of $267.28 per share as on September 17, 2026 at 8:46 am IST.
What is the minimum amount required to buy Johnson & Johnson Stock (JNJ) from India?
Indian investors can start investing in Johnson & Johnson (JNJ) shares with as little as ₹95.94 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹959.40 in Johnson & Johnson stock (as per the Rupee-Dollar exchange rate as on ).
Based on Johnson & Johnson share’s latest price of $267.28 as on September 17, 2026 at 8:46 am IST, you will get 0.0374 shares of Johnson & Johnson. Learn more about
fractional shares .
What are the returns that Johnson & Johnson has given to Indian investors in the last 5 years?
Johnson & Johnson stock has given 61% share price returns and 29.9% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?